New analysis from the IMPACT-TD Registry demonstrates that treatment with AUSTEDO and AUSTEDO XR led to reductions in Abnormal Involuntary ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new post-hoc data from the KINECT® 4 clinical trial demonstrating that adults with tardive dyskinesia (TD) treated with INGREZZA® ...

Transcranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized patients with ...

The gold standard is the Abnormal Involuntary Movement Scale, or the AIMS, although generally we kind of want to avoid premature TD labels, and we want to ensure that there's a causal link, in this ...

Research has explored possible drivers of sex disparities ...

—That question formed the basis of a new study from the U.K., which sought to learn more about the risk of tardive dyskinesia (TD)—a persistent, potentially irreversible movement disorder—in children ...

The Tardive Dyskinesia Impact Scale demonstrated high discrimination and precision in assessing physical function and socioemotional distress among patients with tardive dyskinesia who received ...

Dr. Carrie Chui (Neurology): A 79-year-old man was admitted to this hospital because of involuntary movements on the left side and transient unresponsiveness. The patient had been in his usual state ...